VEGFA and proliferative diabetic retinopathy: Less visual field loss and less occurrence/worsening of diabetic macular edema (DME) were benefits of anti-VEGF compared to PRP that nowadays clinicians’ and patients’ preferences are the determinants of whether to treat severe non - proliferative diabetic retinopathy (NPDR) or PDR with anti-VEGF or PRP.